TY  - JOUR
T1  - Generic pills from the patient perspective: Comment on “variations in pill appearance of antiepileptic drugs and the risk of nonadherence”
AU  - Yu LX, Geba GP
Y1  - 2013/02/11
N1  - 10.1001/jamainternmed.2013.2283
JO  - JAMA Internal Medicine
SP  - 208
EP  - 209
VL  - 173
IS  - 3
N2  - 
Generic drug products are becoming increasingly important to health care. Nearly 80% of prescriptions filled in the United States are for generic drugs. At the US Food and Drug Administration (FDA), the Office of Generic Drugs (OGD) is responsible for the approval of generic drug products. The OGD assesses the safety, efficacy, and quality of generic drug products by making a finding of pharmaceutical equivalence and “bioequivalence.” A key principle is that generic drug products that reach health care providers and patients must be scientifically verified as appropriately substitutable for the brand-name products that are listed by the FDA as reference products.

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.2283
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.2283
ER  -